Healthcare & Pharmaceuticals
The health care landscape continues to emerge with new and different business models, changing competitive boundaries, and unprecedented political uncertainly. Controversy and debate only continues to get more complicated as we approach a very important election. Our roundtable includes the viewpoints from S&P Global Rating’s three health care teams: Health Insurance, For-Profit Health Care, and Not-For-Profit Health Care.
Access our most recent Ratings Actions.
Latest Healthcare & Pharmaceuticals ResearchSEE ALL RESEARCH & INSIGHTS
- Canada, APAC, EMEA, APAC, United States of America, Latin America
The Health Care Credit Beat: Has The U.S. Generic Pharma Sector Hit Rock Bottom?Read
- Canada, APAC, United States of America, APAC, EMEA, Latin America
Health Care Legislation Guide: With The Rebate Rule Off The Table, What Else Is Lurking?Read
Industry Top Trends Update North America Health CareRead
Industry Top Trends Update EMEA Health CareRead
ESG Industry Report Card: Health CareRead
- United States of America, APAC, EMEA, Latin America
The Pharma Industry Outlook Is Negative On M&A, Pricing Pressure, Regulatory Scrutiny, And Opioid LitigationRead